Your browser doesn't support javascript.
loading
Phase I Study of Alvocidib Followed by 7+3 (Cytarabine + Daunorubicin) in Newly Diagnosed Acute Myeloid Leukemia.
Zeidner, Joshua F; Lee, Daniel J; Frattini, Mark; Fine, Gil D; Costas, Judy; Kolibaba, Kathryn; Anthony, Stephen P; Bearss, David; Smith, B Douglas.
Afiliação
  • Zeidner JF; University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina. joshua_zeidner@med.unc.edu.
  • Lee DJ; Columbia University Medical Center, New York, New York.
  • Frattini M; Columbia University Medical Center, New York, New York.
  • Fine GD; Celgene, Summit, New Jersey.
  • Costas J; Sumitomo Dainippon Pharma Oncology, Lehi, Utah.
  • Kolibaba K; Sumitomo Dainippon Pharma Oncology, Lehi, Utah.
  • Anthony SP; Sumitomo Dainippon Pharma Oncology, Lehi, Utah.
  • Bearss D; Sumitomo Dainippon Pharma Oncology, Lehi, Utah.
  • Smith BD; Sumitomo Dainippon Pharma Oncology, Lehi, Utah.
Clin Cancer Res ; 27(1): 60-69, 2021 01 01.
Article em En | MEDLINE | ID: mdl-32998965
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Daunorrubicina / Recidiva Local de Neoplasia Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Daunorrubicina / Recidiva Local de Neoplasia Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article